| 1 | 6544-00-9 | Silicic acid, hexapropyl ester | C18H42O7Si2 | 426.69 | | |
| 2 | 6544-02-1 | 四异硫氰酸硅 | C4N4S4Si | 260.42 | | |
| 3 | 6544-06-5 | Bicyclo[12.2.2]octadeca-14,16(1),17-triene | | | | |
| 4 | 6544-33-8 | 4-ethyltetrahydro-5-oxofuran-3-acetic acid | C8H12O4 | 172.17848 | | |
| 5 | 6544-40-7 | (R)-5-methyl-2-(1-methylvinyl)hex-4-enal | C10H16O | 152.23 | | |
| 6 | 6544-68-9 | 18a-Methylestrone | C19H24O2 | 284.39 | | |
| 7 | 6544-69-0 | Gona-1,3,5(10)-triene-3,17-diol, 13-ethyl-, (17β)- | C19H26O2 | 286.41 | | |
| 8 | 6544-70-3 | B-Norcholesterol | C26H44O | 372.62696 | | |
| 9 | 6544-76-9 | 7H-Furo[3,2-f][1]benzopyran-7-one | C11H6O3 | 186.16 | 147-148 °C | |
| 10 | 6544-77-0 | Benzo1,2-b:3,4-cdifuran-1,3-dione, 3a,4,8a,8b-tetrahydro- | C10H8O4 | 192.17 | | |
| 11 | 6544-81-6 | CHEMBRDG-BB 6662303 | C14H16O5 | 264.27 | | |
| 12 | 65440-41-7 | 5-bromo-8-nitronaphthalene-1-carboxylic acid | C11H6BrNO4 | 296.07 | 260 °C | |
| 13 | 65440-68-8 | Benzenesulfinamide, 4-methyl-N-(1-phenylethylidene)-, (S)- | C15H15NOS | 257.35 | | |
| 14 | 65440-93-9 | (PERFLUOROHEXYL)BENZENE | C12H5F13 | 396.15 | | |
| 15 | 65441-03-4 | 4-(4-Methoxyphenyl)-1H-2,3-benzoxazin-1-one | C15H11NO3 | 253.25 | 141 °C | |
| 16 | 65441-59-0 | 19-Norlanostane, 9-methyl-, (5ξ,9β,10α)- | C30H54 | 414.75 | | |
| 17 | 65441-77-2 | Benzoicacid, 2-chloro-, 4,5-dihydro-3,5,5-trimethyl-3H-pyrazol-3-yl ester | C13H15ClN2O2 | 266.7234 | | |
| 18 | 65441-78-3 | Benzoic acid,4-chloro-, 4,5-dihydro-3,5,5-trimethyl-3H-pyrazol-3-yl ester | C13H15ClN2O2 | 266.7234 | | |
| 19 | 65441-83-0 | (3,5,5-trimethyl-1-oxido-4H-pyrazol-3-yl) benzoate | C13H16N2O3 | 248.28 | | |
| 20 | 65441-88-5 | NSC 265476 | C13H15FN2O3 | 266.2682032 | | |
| 21 | 65441-90-9 | 3H-Pyrazol-3-ol,4,5-dihydro-3,5,5-trimethyl-, 3-(4-nitrobenzoate) 1-oxide | C13H16N3O5 | 294.28324 | | |
| 22 | 65441-91-0 | 3H-Pyrazol-3-ol, 4,5-dihydro-3,5,5-trimethyl-, 3-benzoate, 2-oxide | C13H16N2O3 | 248.28 | | |
| 23 | 65441-96-5 | Benzoic acid, 4-fluoro-, 4,5-dihydro-3,5,5-trimethyl-2-oxido-3H-pyrazol-3-yl ester | C13H15FN2O3 | 266.27 | | |
| 24 | 65441-97-6 | Benzoicacid, 4-methoxy-, 4,5-dihydro-3,5,5-trimethyl-2-oxido-3H-pyrazol-3-yl ester | C14H19N2O4- | 279.31166 | | |
| 25 | 65441-98-7 | 3H-Pyrazol-3-ol, 4,5-dihydro-3,5,5-trimethyl-, 3-(4-nitrobenzoate) 2-oxide | C13H15N3O5 | 293.28 | | |
| 26 | 65442-22-0 | DIETHYL 3-METHOXYPHENYLPHOSPHONATE | C11H17O4P | 244.224041 | | |
| 27 | 65442-29-7 | 2-Propenoic acid, 2-methyl-, hexadecyl ester, polymer with isodecyl 2-methyl-2-propenoate and octadecyl 2-methyl-2-propenoate | (C22H42O2.C20H38O2.C14H26O2)x | | | |
| 28 | 65442-30-0 | Glycine, N-(carboxymethyl)-N-[(ethenylphenyl)methyl]-, polymer with diethenylbenzene and 2-ethyl-2-[[(2-methyl-1-oxo- 2-propenyl)oxy]methyl]-1,3-propanediyl bis(2-methyl-2-propenoate) | (C18H26O6.C13H15NO4.C10H10)x | | | |
| 29 | 65442-31-1 | Butyl quinoline secondary | C13H15N | 185.2649 | | 116.4mg/L at 20℃ |
| 30 | 65443-02-9 | methacrylic acid, compound with 2,2',2''-nitrilotriethanol (1:1) | C10H21NO5 | 235.27744 | | |
| 31 | 65443-10-9 | 2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethyl 2-propenoate and 2-(3-oxazolidinyl)ethyl 2-methyl-2-propenoate | C19H31NO7 | 385.46 | | |
| 32 | 65443-14-3 | 5-Pentyl-2,2,5-trimethylcyclopentanone | C13H24O | 196.33 | | 18.9mg/L at 20℃ |
| 33 | 65443-17-6 | 6-Oxabicyclo[3.1.0]hexan-2-one, 5-methyl-1-pentyl- | C11H18O2 | 182.26 | | |
| 34 | 65443-95-0 | L-Leucine, N-[3-(benzoylthio)-1-oxopropyl]- | C16H21NO4S | 323.41 | | |
| 35 | 65444-04-4 | L-Valine, N-(3-mercapto-2-methyl-1-oxopropyl)- | C9H17NO3S | 219.3 | | |
| 36 | 65444-05-5 | Ethanethioic acid, S-[3-chloro-3-oxo-2-(phenylmethyl)propyl] ester | C12H13ClO2S | 256.75 | | |
| 37 | 65444-10-2 | Phosphoric acid 2-methoxyethyldiphenyl ester | C15H17O5P | 308.27 | | |
| 38 | 65444-12-4 | 2'-Amino-2'-deoxycytidine-5'-triphosphate | C9H17N4O13P3 | 482.17 | | |
| 39 | 65444-31-1 | 6-Isobutylquinoline | | | | |
| 40 | 65445-09-2 | norethindrone pivalate | C25H34O3 | 382.54 | | 30.2ug/L(25 ºC) |
| 41 | 65445-14-9 | 1α-Hydroxy-5,6-trans-vitamin D3 | C27H44O2 | 400.64 | | |
| 42 | 65445-15-0 | 1α-hydroxy-5,6-trans-vitamin D3 | C27H44O2 | 400.65 | | |
| 43 | 65445-21-8 | RUBROLONE | C23H23NO8 | 441.43 | | |
| 44 | 65445-59-2 | 3,5-DIMETHYLNITROSOPIPERIDINE | C7H14N2O | 142.2 | | |
| 45 | 65445-60-5 | 3-chloronitrosopiperidine | C5H9ClN2O | 148.59 | | |
| 46 | 65445-61-6 | 4-Chloro-N-nitrosopiperidine | C5H9ClN2O | 148.59 | | |
| 47 | 65445-62-7 | N-Nitroso Nipecotic Acid | C6H10N2O3 | 158.16 | | |
| 48 | 65445-68-3 | L-Serine, N-acetyl-O-(4-methylphenyl)- | C12H15NO4 | 237.25 | | |
| 49 | 65445-69-4 | L-Serine, N-acetyl-O-phenyl- | C11H13NO4 | 223.23 | | |
| 50 | 65445-74-1 | 1,2-dihydropyridazine-3,6-dione, compound with dimethylamine (1:1) | C6H11N3O2 | 157.17044 | | |
| 51 | 65445-77-4 | N,N-Dimethyl-2-aminomethyl-4,4-diphenylcyclohexanone hydrochloride | | | | |
| 52 | 65445-78-5 | Dimethylaminomethyl-3,3-diphenylcyclohexane hydrochloride | | | 225 °C(Solv: isopropanol (67-63-0)) | |
| 53 | 65445-80-9 | Cyclohexanol, 2-[(dimethylamino)methyl]-4,4-diphenyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI) | C25H33NO7 | 459.54 | | |
| 54 | 65445-82-1 | (4,4-diphenyl-1-cyclohexenyl)methanamine hydrochloride | C19H22ClN | | | |
| 55 | 65445-86-5 | but-2-enedioic acid, (4,4-diphenylcyclohexyl)methanamine | C23H27NO4 | | | |
| 56 | 65446-01-7 | Cyclohexanemethanamine, N,N-dimethyl-3,3-diphenyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) | C25H33NO6 | 443.54 | | |
| 57 | 65446-07-3 | Tetradecanoic acid, (2R)-2-hydroxy-3-(phosphonooxy)propyl ester | C17H35O7P | 382.43 | | |
| 58 | 65446-08-4 | 5,8,11,14-Eicosatetraenoic acid, (2R)-2-hydroxy-3-(phosphonooxy)propyl ester, (5Z,8Z,11Z,14Z)- | C23H39O7P | 458.53 | | |
| 59 | 65446-19-7 | 4-O-Desmethyldoxorubicinone | C20H16O9 | 400.34 | | |
| 60 | 65446-24-4 | 2-Chloro-4-nitrophenyl-a-D-mannopyranoside | C12H14ClNO8 | 335.69 | | |
| 61 | 65446-30-2 | Aziridine, 1-ethyl-2,3-diphenyl-, (2R,3R)-rel- | C16H17N | 223.31 | | |
| 62 | 65446-56-2 | 2'-bromo-2'-deoxyadenosine | C10H12BrN5O3 | 330.14 | | |
| 63 | 65446-79-9 | Morpholine, 4-[5-(dipropylamino)-4-hydroxy-2-methyl-1-oxopentyl]-, monohydrochloride (9CI) | C16H33ClN2O3 | 336.9 | | |
| 64 | 65446-85-7 | N,N-Diethyl-gamma-hydroxy-4-morpholinepentanamide monohydrochloride | | | | |
| 65 | 65446-86-8 | N,N-Dibutyl-gamma-hydroxy-4-morpholinepentanamide monohydrochloride | | | 155-157 °C | |
| 66 | 65446-89-1 | Morpholine, 4-(4-(benzoyloxy)-5-(dipropylamino)-1-oxopentyl)-, monohyd rochloride | | | 135-137 °C | |
| 67 | 65446-96-0 | Acetamide, 2-(diethylamino)-N-(4-methylphenyl)- | C13H20N2O | 220.3107 | | |
| 68 | 65447-43-0 | 5-nitro-4-(4-propoxyphenyl)-1H-imidazole | C12H13N3O3 | 247.25 | | |
| 69 | 65447-49-6 | 2-Bromo-1-(4-methoxy-3-nitrophenyl)-1-ethanone | C9H8BrNO4 | 274.07 | 94-96° | |
| 70 | 65447-58-7 | 1H-Pyrazole, 1,3-dimethyl-4-(1-propynyl)- (9CI) | C8H10N2 | 134.18 | | |
| 71 | 65447-77-0 | Photo-stabilizer BW-10LD | C17H33NO6 | 347.45 | >350°C(lit.) | 1.6 ppm at 20 ºC |
| 72 | 65448-54-6 | 1H-Benz[de]isoquinoline, 2,3-dihydro-2-(phenylmethyl)- | C19H17N | 259.35 | | |
| 73 | 65448-72-8 | 3-(hydroxymethyl)-5-methylsalicylaldehyde | C9H10O3 | 166.17 | | |
| 74 | 65448-98-8 | N,N,N,N',N',N'-Hexaethyl-(1,1':4',1''-terbenzene)-4,4''-diaminium | | | | |
| 75 | 65448-99-9 | terkuronii | C42H52N2O6S2 | 745.00208 | | |
| 76 | 65449-53-8 | 2-[(2-chlorothiophen-3-yl)oxy]acetic Acid | C6H5ClO3S | 192.62 | | |
| 77 | 65449-59-4 | METHYL 4-CHLORO-3-HYDROXYTHIOPHENE-2-CARBOXYLATE | C6H5ClO3S | 192.62 | | |
| 78 | 65449-71-0 | 1,2-Benzisothiazole-5-acetamide, 3-methoxy- | C10H10N2O2S | 222.2636 | | |